Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

cyclopia sequence 8Neoplasms, Plasma Cell 2Multiple Myeloma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Pain 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Hypesthesia 1Head and Neck Neoplasms 1Exanthema 1Esophageal Neoplasms 1Depression 1Colorectal Neoplasms 1Anxiety Disorders 1Acute Pain 1

Interventions

Gemcitabine 295Fluorouracil 82Oxaliplatin 81130-nm albumin-bound paclitaxel 68Capecitabine 60Leucovorin 56Albumin-Bound Paclitaxel 54Radiotherapy 51Irinotecan 44Taxes 37Cisplatin 36Erlotinib Hydrochloride 34Radiosurgery 33pembrolizumab 29Docetaxel 27S 1 (combination) 26Bevacizumab 23folfirinox 22Nivolumab 21Magnetic Resonance Spectroscopy 17Cyclophosphamide 17Cetuximab 17irinotecan sucrosofate 16Radiation 16Drug Therapy 15Surgical Procedures, Operative 14Specimen Handling 11Biopsy 11durvalumab 10Paclitaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Pancreatic Neoplasms × Minocycline × Clear all
NCT01693523 2020-03-09

Minocycline Study in Pancreatic Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Completed
80 enrolled 10 charts
Gastrointestinal

cyclopia sequence, Neoplasm Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡